- Open
- 107.75
- High
- 108.00
- Low
- 107.00
- Close
- 107.14
- Change
- -0.40 (-0.37%)
- Volume
- 142,519
| 6 Aug 2026 | 07:00:05 | First Quarter Update |
| 4 Aug 2026 | 14:00:01 | Holding(s) in Company |
| 3 Aug 2026 | 07:00:07 | Total Voting Rights |
| 30 Jul 2026 | 14:00:01 | Holding(s) in Company |
| 23 Jul 2026 |
| 2 Jul 2025 | Annual Report and Accounts 2025 | |
| 4 Jul 2024 | Annual Report and Accounts 2024 | |
| 28 Jun 2023 | Annual Report and Accounts 2023 |
Syncona Limited invests in and develops companies within the biotechnology and healthcare sectors, focusing on therapies that address significant medical challenges. Its investment objective is to support businesses that aim to improve and prolong human life. The trust operates primarily in the life sciences sector, making it a peer of other trusts with similar mandates and geographic focus.
| 6 Aug 2026 | 07:00:05 | First Quarter Update |
| 4 Aug 2026 | 14:00:01 | Holding(s) in Company |
| 3 Aug 2026 | 07:00:07 | Total Voting Rights |
| 30 Jul 2026 | 14:00:01 | Holding(s) in Company |
| 23 Jul 2026 |
| 2 Jul 2025 | Annual Report and Accounts 2025 | |
| 4 Jul 2024 | Annual Report and Accounts 2024 | |
| 28 Jun 2023 | Annual Report and Accounts 2023 |
Syncona Limited invests in and develops companies within the biotechnology and healthcare sectors, focusing on therapies that address significant medical challenges. Its investment objective is to support businesses that aim to improve and prolong human life. The trust operates primarily in the life sciences sector, making it a peer of other trusts with similar mandates and geographic focus.
| 09:49:13 |
| Issue of Shares pursuant to Incentive Scheme |
| 22 Jun 2026 |
| Director dealings: Syncona non-executive director snaps up shares |
| 22 Jun 2026 | FTSE 250 movers: Ocado under cosh; easyJet flies higher |
| 18 Jun 2026 | Morning briefing: Aberdeen New India slumps 20% in year to March; Norman Crighton joins Syncona board as life science fund pursues £250m capital return |
| 18 Jun 2026 | Syncona pivots towards shareholder returns as biotech portfolio matures |
| 14 May 2026 | SYNCONA LIMITED ORD NPV (SYNC.L) Stock Analysis: Unlocking a 116.51% Potential Upside in Asset Management |
| 09:49:13 |
| Issue of Shares pursuant to Incentive Scheme |
| 22 Jun 2026 |
| Director dealings: Syncona non-executive director snaps up shares |
| 22 Jun 2026 | FTSE 250 movers: Ocado under cosh; easyJet flies higher |
| 18 Jun 2026 | Morning briefing: Aberdeen New India slumps 20% in year to March; Norman Crighton joins Syncona board as life science fund pursues £250m capital return |
| 18 Jun 2026 | Syncona pivots towards shareholder returns as biotech portfolio matures |
| 14 May 2026 | SYNCONA LIMITED ORD NPV (SYNC.L) Stock Analysis: Unlocking a 116.51% Potential Upside in Asset Management |
| Issuer | Mkt cap | 1Y |
|---|---|---|
| £1.56bn | +0.2% | |
SYNCSyncona Limited | £721m | +0.1% |
| £549m | +0.4% | |
| £449m | +0.6% | |
| £250m | +0.1% | |
| £66m | +0.2% |
| Issuer | Mkt cap | 1Y |
|---|---|---|
| £1.56bn | +0.2% | |
SYNCSyncona Limited | £721m | +0.1% |
| £549m | +0.4% | |
| £449m | +0.6% | |
| £250m | +0.1% | |
| £66m | +0.2% |
